Although we managed to quantify low DUX4 gene expression in DUX4-TG muscles, DUX4 expression is quite difficult to detect in FSHD-patient-derived muscle biopsies due to its fairly low expression [7], which makes the clinical evaluation of ASOs in FSHD patients difficult. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.